Anti-invasive and anti-angiogenic activities of naturally occurring dibenzodiazepine BU-4664L and its derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 3, 2010, Pages 963-965

  Miyanaga, Satoshi ^a   Sakurai, Hiroaki ^b   Saiki, Ikuo ^b   Onaka, Hiroyasu ^a   Igarashi, Yasuhiro ^a  

^a TOYAMA PREFECTURAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Angiogenesis; BU 4664L; Dibenzodiazepine; Invasion

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BENZODIAZEPINE DERIVATIVE; BU 4664L; GELATINASE A; GELATINASE B; UNCLASSIFIED DRUG; 5,10-DIHYDRO-4,6,8-TRIHYDROXY-10-(3,7,11-TRIMETHYL-2,6,10-DODECATRIENYL)-11H-DIBENZO(B,E)(1,4)DIAZEPIN-11-ONE; DIBENZAZEPINE DERIVATIVE; SESQUITERPENE;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; ANIMAL; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; NEOPLASM INVASIVENESS; TUMOR CELL LINE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; DIBENZAZEPINES; HUMANS; MICE; NEOPLASM INVASIVENESS; SESQUITERPENES;

EID: 74049086807     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.12.055     Document Type: Article

References (23)

1. Kohn E.C., and Liotta L.A. Cancer Res. 51 (1995) 1856
2. Folkman J. Nat. Med. 1 (1995) 27
3. Woodhouse E.C., Chuaqui R.F., and Liotta L.A. Cancer 80 (1997) 1529
4. Miyanaga S., Obata T., Onaka H., Fujita T., Saito N., Sakurai H., Saiki I., Furumai T., and Igarashi Y. J. Antibiot. 59 (2006) 698
5. Igarashi Y., Trujillo M.E., Martinez-Molina E., Yanase S., Miyanaga S., Obata T., Sakurai H., Saiki I., Fujita T., and Furumai T. Bioorg. Med. Chem. Lett. 17 (2007) 3702
6. Igarashi Y., Mogi T., Yanase S., Miyanaga S., Fujita T., Sakurai H., Saiki I., and Ohsaki A. J. Nat. Prod. 72 (2009) 980
7. Ohkuma, H.; Kobaru, S. U.S. Patent 5,541,181, 1996.
8. Igarashi Y., Miyanaga S., Onaka H., Takeshita M., and Furumai T. J. Antibiot. 58 (2005) 350
9. Gourdeau H., McAlpine J.B., Ranger M., Simard B., Berger F., Beaudry F., and Falardeau P. Cancer Chemother. Pharmacol. 61 (2008) 911
10. Saito K.I., Oku T., Ata N., Miyashiro H., Hattori M., and Saiki I. Biol. Pharm. 20 (1997) 345
11. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., and Shafie S. Nature 284 (1980) 67
12. Saitoh Y., Koizumi K., Minami T., Sekine K., Sakurai H., and Saiki I. Biol. Pharm. Bull. 29 (2006) 709
13. 7Na, 611.2728).
14. 4Na, 527.2880).
15. 4Na, 491.2880).
16. 4Na, 533.3350).
17. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., and Folkman J. Nature 348 (1990) 555
18. Zhu K., Hamilton A.D., and Sebti S.M. Curr. Opin. Invest. Drugs 4 (2003) 1428
19. Pytel D., Sliwinski T., Poplawski T., Ferriola D., and Majsterek I. Anticancer Agents Med. Chem. 9 (2009) 66
20. Diazepinomicin and ECO-04601 appear to be same as BU-4664L. Charan, R. D.; Schlingmann, G.; Janso, J.; Bernan, V.; Feng, X.; Carter, G. T. J. Nat. Prod. 2004, 67, 1431; Bachmann, B. O.; McAlpine, J. B.; Zazapoulos, E.; Farnet, C. M.; Piraee, M. WO 2004/065591, 2004.
21. Watanabe T., Kakefuda A., Tanaka A., Takizawa K., Hirano S., Shibata H., Yamagiwa Y., and Yanagisawa I. Chem. Pharm. Bull. 46 (1998) 53
22. Cohen V.I., Gitler M.S., de la Cruz R.A., Boulay S.F., Sood V.K., Zeeberg B.R., and Reba R.C. Eur. J. Med. Chem. 30 (1995) 61
23. Goodfellow M., Potterat O., Puder C., and Mihm G. Antonie Van Leeuwenhoek 87 (2005) 37